- Home
- ALAR vs NTHI Comparison
ALAR vs NTHI Comparison
Compare ALAR & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- NTHI
- Stock Information
- Founded
- ALAR 2013
- NTHI 2008
- Country
- ALAR Israel
- NTHI United States
- Employees
- ALAR N/A
- NTHI N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- NTHI Health Care
- Exchange
- ALAR Nasdaq
- NTHI Nasdaq
- Market Cap
- ALAR 116.1M
- NTHI 111.5M
- IPO Year
- ALAR 2018
- NTHI N/A
- Fundamental
- Price
- ALAR $16.55
- NTHI $5.85
- Analyst Decision
- ALAR Strong Buy
- NTHI
- Analyst Count
- ALAR 1
- NTHI 0
- Target Price
- ALAR $15.00
- NTHI N/A
- AVG Volume (30 Days)
- ALAR 90.6K
- NTHI 320.0K
- Earning Date
- ALAR 08-28-2025
- NTHI 08-19-2025
- Dividend Yield
- ALAR N/A
- NTHI N/A
- EPS Growth
- ALAR N/A
- NTHI N/A
- EPS
- ALAR 0.07
- NTHI N/A
- Revenue
- ALAR $30,581,000.00
- NTHI $59,990.00
- Revenue This Year
- ALAR $11.54
- NTHI N/A
- Revenue Next Year
- ALAR $19.42
- NTHI N/A
- P/E Ratio
- ALAR $24.94
- NTHI N/A
- Revenue Growth
- ALAR 4.67
- NTHI N/A
- 52 Week Low
- ALAR $5.45
- NTHI $3.20
- 52 Week High
- ALAR $22.44
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- ALAR 66.68
- NTHI N/A
- Support Level
- ALAR $15.65
- NTHI N/A
- Resistance Level
- ALAR $17.27
- NTHI N/A
- Average True Range (ATR)
- ALAR 0.92
- NTHI 0.00
- MACD
- ALAR 0.11
- NTHI 0.00
- Stochastic Oscillator
- ALAR 83.56
- NTHI 0.00
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").